GlassScriptPhysician profile
Patrick R Knight
NPI 1871595264
$1,751.47
in general payments reported to CMS, 2019-2025
11 companies · $64.61 in 2025
The $64.61 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $463 · 2020: $29.62 · 2022: $477 · 2023: $205 · 2024: $512 · 2025: $64.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $781.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $908.23 | 2022-2024 | Mako, Triathlon, Insignia |
| Pacira Therapeutics, INC. | $242.71 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $205.42 | 2019-2022 | |
| Heraeus Medical, LLC. | $189.90 | 2022-2025 | |
| Endo Pharmaceuticals INC. | $56.37 | 2019-2020 | |
| Depuy Synthes Sales INC. | $56.35 | 2019 | |
| Amgen INC. | $34.48 | 2019 | |
| Convatec INC. | $18.77 | 2019 | |
| Ebi, LLC | $18.07 | 2025 | Biomet Ebi Bone Healing System |
| Ferring Pharmaceuticals INC. | $11.12 | 2019 | |
| Arteriocyte Medical Systems, INC. | $10.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Knight listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.